【市場調査レポート】前立腺がん診断ソリューションのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Prostate Cancer Diagnostics Solution Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。前立腺がん診断ソリューションのグローバル市場インサイト・予測（～2028年） / Global Prostate Cancer Diagnostics Solution Market Insights, Forecast to 2028 / QY2207E10028資料のイメージです。

• レポートコード：QY2207E10028
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、113ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の前立腺がん診断ソリューションの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に前立腺がん診断ソリューションの世界市場のxxx％を占める「腫瘍バイオマーカー検査」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「55歳以下」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の前立腺がん診断ソリューションの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの前立腺がん診断ソリューション市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの前立腺がん診断ソリューション市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

前立腺がん診断ソリューションのグローバル主要メーカーには、OPKO、Genomic Health、Abbott、Beckman Coulter、Siemens Healthcare、bioMeriux、Roche、MDx Health、DiaSorin、Myriad Genetics、Ambry Geneticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

前立腺がん診断ソリューション市場は、種類と用途によって区分されます。世界の前立腺がん診断ソリューション市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
腫瘍バイオマーカー検査、画像診断、生検、その他

【用途別セグメント】
55歳以下、55〜75歳、75歳以上

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 前立腺がん診断ソリューション製品概要
- 種類別市場（腫瘍バイオマーカー検査、画像診断、生検、その他）
- 用途別市場（55歳以下、55〜75歳、75歳以上）
- 調査の目的
・エグゼクティブサマリー
- 世界の前立腺がん診断ソリューション販売量予測2017-2028
- 世界の前立腺がん診断ソリューション売上予測2017-2028
- 前立腺がん診断ソリューションの地域別販売量
- 前立腺がん診断ソリューションの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別前立腺がん診断ソリューション販売量
- 主要メーカー別前立腺がん診断ソリューション売上
- 主要メーカー別前立腺がん診断ソリューション価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（腫瘍バイオマーカー検査、画像診断、生検、その他）
- 前立腺がん診断ソリューションの種類別販売量
- 前立腺がん診断ソリューションの種類別売上
- 前立腺がん診断ソリューションの種類別価格
・用途別市場規模（55歳以下、55〜75歳、75歳以上）
- 前立腺がん診断ソリューションの用途別販売量
- 前立腺がん診断ソリューションの用途別売上
- 前立腺がん診断ソリューションの用途別価格
・北米市場
- 北米の前立腺がん診断ソリューション市場規模（種類別、用途別）
- 主要国別の前立腺がん診断ソリューション市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの前立腺がん診断ソリューション市場規模（種類別、用途別）
- 主要国別の前立腺がん診断ソリューション市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の前立腺がん診断ソリューション市場規模（種類別、用途別）
- 主要国別の前立腺がん診断ソリューション市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の前立腺がん診断ソリューション市場規模（種類別、用途別）
- 主要国別の前立腺がん診断ソリューション市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの前立腺がん診断ソリューション市場規模（種類別、用途別）
- 主要国別の前立腺がん診断ソリューション市場規模（トルコ、サウジアラビア）
・企業情報
OPKO、Genomic Health、Abbott、Beckman Coulter、Siemens Healthcare、bioMeriux、Roche、MDx Health、DiaSorin、Myriad Genetics、Ambry Genetics
・産業チェーン及び販売チャネル分析
- 前立腺がん診断ソリューションの産業チェーン分析
- 前立腺がん診断ソリューションの原材料
- 前立腺がん診断ソリューションの生産プロセス
- 前立腺がん診断ソリューションの販売及びマーケティング
- 前立腺がん診断ソリューションの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 前立腺がん診断ソリューションの産業動向
- 前立腺がん診断ソリューションのマーケットドライバー
- 前立腺がん診断ソリューションの課題
- 前立腺がん診断ソリューションの阻害要因
・主な調査結果

Market Analysis and Insights: Global Prostate Cancer Diagnostics Solution Market
The global Prostate Cancer Diagnostics Solution market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Tumor Biomarker Tests accounting for % of the Prostate Cancer Diagnostics Solution global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Age Below 55 segment is altered to an % CAGR throughout this forecast period.
China Prostate Cancer Diagnostics Solution market size is valued at US$ million in 2021, while the North America and Europe Prostate Cancer Diagnostics Solution are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Prostate Cancer Diagnostics Solution landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Cancer Diagnostics Solution market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Cancer Diagnostics Solution market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Cancer Diagnostics Solution market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Cancer Diagnostics Solution market.
Global Prostate Cancer Diagnostics Solution Scope and Market Size
Prostate Cancer Diagnostics Solution market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Diagnostics Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Tumor Biomarker Tests
Imaging
Biopsy
Other
Segment by Application
Age Below 55
Age 55-75
Age Above 75
By Company
OPKO
Genomic Health
Abbott
Beckman Coulter
Siemens Healthcare
bioMeriux
Roche
MDx Health
DiaSorin
Myriad Genetics
Ambry Genetics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Diagnostics Solution Market Perspective (2017-2028)
2.2 Prostate Cancer Diagnostics Solution Growth Trends by Region
2.2.1 Prostate Cancer Diagnostics Solution Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Prostate Cancer Diagnostics Solution Historic Market Size by Region (2017-2022)
2.2.3 Prostate Cancer Diagnostics Solution Forecasted Market Size by Region (2023-2028)
2.3 Prostate Cancer Diagnostics Solution Market Dynamics
2.3.1 Prostate Cancer Diagnostics Solution Industry Trends
2.3.2 Prostate Cancer Diagnostics Solution Market Drivers
2.3.3 Prostate Cancer Diagnostics Solution Market Challenges
2.3.4 Prostate Cancer Diagnostics Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Diagnostics Solution Players by Revenue
3.1.1 Global Top Prostate Cancer Diagnostics Solution Players by Revenue (2017-2022)
3.1.2 Global Prostate Cancer Diagnostics Solution Revenue Market Share by Players (2017-2022)
3.2 Global Prostate Cancer Diagnostics Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Diagnostics Solution Revenue
3.4 Global Prostate Cancer Diagnostics Solution Market Concentration Ratio
3.4.1 Global Prostate Cancer Diagnostics Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics Solution Revenue in 2021
3.5 Prostate Cancer Diagnostics Solution Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Diagnostics Solution Product Solution and Service
3.7 Date of Enter into Prostate Cancer Diagnostics Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Diagnostics Solution Breakdown Data by Type
4.1 Global Prostate Cancer Diagnostics Solution Historic Market Size by Type (2017-2022)
4.2 Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Type (2023-2028)
5 Prostate Cancer Diagnostics Solution Breakdown Data by Application
5.1 Global Prostate Cancer Diagnostics Solution Historic Market Size by Application (2017-2022)
5.2 Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Prostate Cancer Diagnostics Solution Market Size (2017-2028)
6.2 North America Prostate Cancer Diagnostics Solution Market Size by Type
6.2.1 North America Prostate Cancer Diagnostics Solution Market Size by Type (2017-2022)
6.2.2 North America Prostate Cancer Diagnostics Solution Market Size by Type (2023-2028)
6.2.3 North America Prostate Cancer Diagnostics Solution Market Share by Type (2017-2028)
6.3 North America Prostate Cancer Diagnostics Solution Market Size by Application
6.3.1 North America Prostate Cancer Diagnostics Solution Market Size by Application (2017-2022)
6.3.2 North America Prostate Cancer Diagnostics Solution Market Size by Application (2023-2028)
6.3.3 North America Prostate Cancer Diagnostics Solution Market Share by Application (2017-2028)
6.4 North America Prostate Cancer Diagnostics Solution Market Size by Country
6.4.1 North America Prostate Cancer Diagnostics Solution Market Size by Country (2017-2022)
6.4.2 North America Prostate Cancer Diagnostics Solution Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Prostate Cancer Diagnostics Solution Market Size (2017-2028)
7.2 Europe Prostate Cancer Diagnostics Solution Market Size by Type
7.2.1 Europe Prostate Cancer Diagnostics Solution Market Size by Type (2017-2022)
7.2.2 Europe Prostate Cancer Diagnostics Solution Market Size by Type (2023-2028)
7.2.3 Europe Prostate Cancer Diagnostics Solution Market Share by Type (2017-2028)
7.3 Europe Prostate Cancer Diagnostics Solution Market Size by Application
7.3.1 Europe Prostate Cancer Diagnostics Solution Market Size by Application (2017-2022)
7.3.2 Europe Prostate Cancer Diagnostics Solution Market Size by Application (2023-2028)
7.3.3 Europe Prostate Cancer Diagnostics Solution Market Share by Application (2017-2028)
7.4 Europe Prostate Cancer Diagnostics Solution Market Size by Country
7.4.1 Europe Prostate Cancer Diagnostics Solution Market Size by Country (2017-2022)
7.4.2 Europe Prostate Cancer Diagnostics Solution Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size (2017-2028)
8.2 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Type
8.2.1 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Prostate Cancer Diagnostics Solution Market Share by Type (2017-2028)
8.3 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Application
8.3.1 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Prostate Cancer Diagnostics Solution Market Share by Application (2017-2028)
8.4 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region
8.4.1 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Prostate Cancer Diagnostics Solution Market Size (2017-2028)
9.2 Latin America Prostate Cancer Diagnostics Solution Market Size by Type
9.2.1 Latin America Prostate Cancer Diagnostics Solution Market Size by Type (2017-2022)
9.2.2 Latin America Prostate Cancer Diagnostics Solution Market Size by Type (2023-2028)
9.2.3 Latin America Prostate Cancer Diagnostics Solution Market Share by Type (2017-2028)
9.3 Latin America Prostate Cancer Diagnostics Solution Market Size by Application
9.3.1 Latin America Prostate Cancer Diagnostics Solution Market Size by Application (2017-2022)
9.3.2 Latin America Prostate Cancer Diagnostics Solution Market Size by Application (2023-2028)
9.3.3 Latin America Prostate Cancer Diagnostics Solution Market Share by Application (2017-2028)
9.4 Latin America Prostate Cancer Diagnostics Solution Market Size by Country
9.4.1 Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2017-2022)
9.4.2 Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size (2017-2028)
10.2 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Type
10.2.1 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Prostate Cancer Diagnostics Solution Market Share by Type (2017-2028)
10.3 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Application
10.3.1 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Prostate Cancer Diagnostics Solution Market Share by Application (2017-2028)
10.4 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country
10.4.1 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Prostate Cancer Diagnostics Solution Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 OPKO
11.1.1 OPKO Company Details
11.1.2 OPKO Business Overview
11.1.3 OPKO Prostate Cancer Diagnostics Solution Introduction
11.1.4 OPKO Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
11.1.5 OPKO Recent Developments
11.2 Genomic Health
11.2.1 Genomic Health Company Details
11.2.2 Genomic Health Business Overview
11.2.3 Genomic Health Prostate Cancer Diagnostics Solution Introduction
11.2.4 Genomic Health Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
11.2.5 Genomic Health Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Prostate Cancer Diagnostics Solution Introduction
11.3.4 Abbott Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
11.3.5 Abbott Recent Developments
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Prostate Cancer Diagnostics Solution Introduction
11.4.4 Beckman Coulter Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
11.4.5 Beckman Coulter Recent Developments
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Details
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Prostate Cancer Diagnostics Solution Introduction
11.5.4 Siemens Healthcare Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
11.5.5 Siemens Healthcare Recent Developments
11.6 bioMeriux
11.6.1 bioMeriux Company Details
11.6.2 bioMeriux Business Overview
11.6.3 bioMeriux Prostate Cancer Diagnostics Solution Introduction
11.6.4 bioMeriux Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
11.6.5 bioMeriux Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Prostate Cancer Diagnostics Solution Introduction
11.7.4 Roche Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
11.7.5 Roche Recent Developments
11.8 MDx Health
11.8.1 MDx Health Company Details
11.8.2 MDx Health Business Overview
11.8.3 MDx Health Prostate Cancer Diagnostics Solution Introduction
11.8.4 MDx Health Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
11.8.5 MDx Health Recent Developments
11.9 DiaSorin
11.9.1 DiaSorin Company Details
11.9.2 DiaSorin Business Overview
11.9.3 DiaSorin Prostate Cancer Diagnostics Solution Introduction
11.9.4 DiaSorin Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
11.9.5 DiaSorin Recent Developments
11.10 Myriad Genetics
11.10.1 Myriad Genetics Company Details
11.10.2 Myriad Genetics Business Overview
11.10.3 Myriad Genetics Prostate Cancer Diagnostics Solution Introduction
11.10.4 Myriad Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
11.10.5 Myriad Genetics Recent Developments
11.11 Ambry Genetics
11.11.1 Ambry Genetics Company Details
11.11.2 Ambry Genetics Business Overview
11.11.3 Ambry Genetics Prostate Cancer Diagnostics Solution Introduction
11.11.4 Ambry Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022)
11.11.5 Ambry Genetics Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Tumor Biomarker Tests
Table 3. Key Players of Imaging
Table 4. Key Players of Biopsy
Table 5. Key Players of Other
Table 6. Global Prostate Cancer Diagnostics Solution Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Prostate Cancer Diagnostics Solution Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Prostate Cancer Diagnostics Solution Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Prostate Cancer Diagnostics Solution Market Share by Region (2017-2022)
Table 10. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Prostate Cancer Diagnostics Solution Market Share by Region (2023-2028)
Table 12. Prostate Cancer Diagnostics Solution Market Trends
Table 13. Prostate Cancer Diagnostics Solution Market Drivers
Table 14. Prostate Cancer Diagnostics Solution Market Challenges
Table 15. Prostate Cancer Diagnostics Solution Market Restraints
Table 16. Global Prostate Cancer Diagnostics Solution Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Prostate Cancer Diagnostics Solution Revenue Share by Players (2017-2022)
Table 18. Global Top Prostate Cancer Diagnostics Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics Solution as of 2021)
Table 19. Ranking of Global Top Prostate Cancer Diagnostics Solution Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics Solution Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prostate Cancer Diagnostics Solution Product Solution and Service
Table 23. Date of Enter into Prostate Cancer Diagnostics Solution Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prostate Cancer Diagnostics Solution Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type (2017-2022)
Table 27. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Prostate Cancer Diagnostics Solution Revenue Market Share by Type (2023-2028)
Table 29. Global Prostate Cancer Diagnostics Solution Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Prostate Cancer Diagnostics Solution Revenue Share by Application (2017-2022)
Table 31. Global Prostate Cancer Diagnostics Solution Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Prostate Cancer Diagnostics Solution Revenue Share by Application (2023-2028)
Table 33. North America Prostate Cancer Diagnostics Solution Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Prostate Cancer Diagnostics Solution Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Prostate Cancer Diagnostics Solution Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Prostate Cancer Diagnostics Solution Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Prostate Cancer Diagnostics Solution Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Prostate Cancer Diagnostics Solution Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Prostate Cancer Diagnostics Solution Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Prostate Cancer Diagnostics Solution Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Prostate Cancer Diagnostics Solution Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Prostate Cancer Diagnostics Solution Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Prostate Cancer Diagnostics Solution Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Prostate Cancer Diagnostics Solution Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Prostate Cancer Diagnostics Solution Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Prostate Cancer Diagnostics Solution Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Prostate Cancer Diagnostics Solution Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Prostate Cancer Diagnostics Solution Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Prostate Cancer Diagnostics Solution Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Prostate Cancer Diagnostics Solution Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Prostate Cancer Diagnostics Solution Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Prostate Cancer Diagnostics Solution Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Prostate Cancer Diagnostics Solution Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Prostate Cancer Diagnostics Solution Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Prostate Cancer Diagnostics Solution Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Prostate Cancer Diagnostics Solution Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Prostate Cancer Diagnostics Solution Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Prostate Cancer Diagnostics Solution Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Prostate Cancer Diagnostics Solution Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Prostate Cancer Diagnostics Solution Market Size by Country (2023-2028) & (US$ Million)
Table 63. OPKO Company Details
Table 64. OPKO Business Overview
Table 65. OPKO Prostate Cancer Diagnostics Solution Product
Table 66. OPKO Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million)
Table 67. OPKO Recent Developments
Table 68. Genomic Health Company Details
Table 69. Genomic Health Business Overview
Table 70. Genomic Health Prostate Cancer Diagnostics Solution Product
Table 71. Genomic Health Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million)
Table 72. Genomic Health Recent Developments
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott Prostate Cancer Diagnostics Solution Product
Table 76. Abbott Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million)
Table 77. Abbott Recent Developments
Table 78. Beckman Coulter Company Details
Table 79. Beckman Coulter Business Overview
Table 80. Beckman Coulter Prostate Cancer Diagnostics Solution Product
Table 81. Beckman Coulter Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million)
Table 82. Beckman Coulter Recent Developments
Table 83. Siemens Healthcare Company Details
Table 84. Siemens Healthcare Business Overview
Table 85. Siemens Healthcare Prostate Cancer Diagnostics Solution Product
Table 86. Siemens Healthcare Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million)
Table 87. Siemens Healthcare Recent Developments
Table 88. bioMeriux Company Details
Table 89. bioMeriux Business Overview
Table 90. bioMeriux Prostate Cancer Diagnostics Solution Product
Table 91. bioMeriux Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million)
Table 92. bioMeriux Recent Developments
Table 93. Roche Company Details
Table 94. Roche Business Overview
Table 95. Roche Prostate Cancer Diagnostics Solution Product
Table 96. Roche Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million)
Table 97. Roche Recent Developments
Table 98. MDx Health Company Details
Table 99. MDx Health Business Overview
Table 100. MDx Health Prostate Cancer Diagnostics Solution Product
Table 101. MDx Health Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million)
Table 102. MDx Health Recent Developments
Table 103. DiaSorin Company Details
Table 104. DiaSorin Business Overview
Table 105. DiaSorin Prostate Cancer Diagnostics Solution Product
Table 106. DiaSorin Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million)
Table 107. DiaSorin Recent Developments
Table 108. Myriad Genetics Company Details
Table 109. Myriad Genetics Business Overview
Table 110. Myriad Genetics Prostate Cancer Diagnostics Solution Product
Table 111. Myriad Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million)
Table 112. Myriad Genetics Recent Developments
Table 113. Ambry Genetics Company Details
Table 114. Ambry Genetics Business Overview
Table 115. Ambry Genetics Prostate Cancer Diagnostics Solution Product
Table 116. Ambry Genetics Revenue in Prostate Cancer Diagnostics Solution Business (2017-2022) & (US$ Million)
Table 117. Ambry Genetics Recent Developments
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Diagnostics Solution Market Share by Type: 2021 VS 2028
Figure 2. Tumor Biomarker Tests Features
Figure 3. Imaging Features
Figure 4. Biopsy Features
Figure 5. Other Features
Figure 6. Global Prostate Cancer Diagnostics Solution Market Share by Application: 2021 VS 2028
Figure 7. Age Below 55 Case Studies
Figure 8. Age 55-75 Case Studies
Figure 9. Age Above 75 Case Studies
Figure 10. Prostate Cancer Diagnostics Solution Report Years Considered
Figure 11. Global Prostate Cancer Diagnostics Solution Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Prostate Cancer Diagnostics Solution Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Prostate Cancer Diagnostics Solution Market Share by Region: 2021 VS 2028
Figure 14. Global Prostate Cancer Diagnostics Solution Market Share by Players in 2021
Figure 15. Global Top Prostate Cancer Diagnostics Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics Solution as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics Solution Revenue in 2021
Figure 17. North America Prostate Cancer Diagnostics Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Prostate Cancer Diagnostics Solution Market Size Market Share by Type (2017-2028)
Figure 19. North America Prostate Cancer Diagnostics Solution Market Size Market Share by Application (2017-2028)
Figure 20. North America Prostate Cancer Diagnostics Solution Market Size Share by Country (2017-2028)
Figure 21. United States Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Prostate Cancer Diagnostics Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Prostate Cancer Diagnostics Solution Market Size Market Share by Type (2017-2028)
Figure 25. Europe Prostate Cancer Diagnostics Solution Market Size Market Share by Application (2017-2028)
Figure 26. Europe Prostate Cancer Diagnostics Solution Market Size Share by Country (2017-2028)
Figure 27. Germany Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Prostate Cancer Diagnostics Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Prostate Cancer Diagnostics Solution Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Prostate Cancer Diagnostics Solution Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Prostate Cancer Diagnostics Solution Market Size Share by Region (2017-2028)
Figure 37. China Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Prostate Cancer Diagnostics Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Prostate Cancer Diagnostics Solution Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Prostate Cancer Diagnostics Solution Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Prostate Cancer Diagnostics Solution Market Size Share by Country (2017-2028)
Figure 47. Mexico Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Prostate Cancer Diagnostics Solution Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Prostate Cancer Diagnostics Solution Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Prostate Cancer Diagnostics Solution Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Prostate Cancer Diagnostics Solution Market Size Share by Country (2017-2028)
Figure 53. Turkey Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Prostate Cancer Diagnostics Solution Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. OPKO Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2017-2022)
Figure 57. Genomic Health Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2017-2022)
Figure 58. Abbott Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2017-2022)
Figure 59. Beckman Coulter Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2017-2022)
Figure 60. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2017-2022)
Figure 61. bioMeriux Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2017-2022)
Figure 62. Roche Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2017-2022)
Figure 63. MDx Health Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2017-2022)
Figure 64. DiaSorin Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2017-2022)
Figure 65. Myriad Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2017-2022)
Figure 66. Ambry Genetics Revenue Growth Rate in Prostate Cancer Diagnostics Solution Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

前立腺特異抗原（PSA）検査のグローバル市場インサイト・予測（～2028年）

Global Prostate Specific Antigen (PSA) Testing Market Insights, Forecast to 2028
QY2207E09279 2022年7月 114Pages
新型コロナウイルス感染症のパンデミックにより、世界の前立腺特異抗原（PSA）検査の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に前立腺特...

次世代がん診断の世界市場2022年-2030年

Next Generation Cancer Diagnostics Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
SRT22JL0067 2022年5月 120Pages
Straits Researchの当調査資料は、世界の次世代がん診断市場を調査対象とし、市場概要、主要企業、種類別分析、用途別分析、アジア太平洋市場、ヨーロッパ市場、北米市場、南米市場、中東・アフリカ市場などの多面的な分析結果をまとめております。当書に掲載されている企業情報には、Cepheid、Ko...

肝臓がん診断の世界市場2022年-2030年

Liver Cancer Diagnostics Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
SRT22JL0010 2022年5月 115Pages
Straits Researchの当調査資料は、世界の肝臓がん診断市場を調査対象とし、市場概要、主要企業、種類別分析、用途別分析、アジア太平洋市場、ヨーロッパ市場、北米市場、南米市場、中東・アフリカ市場などの多面的な分析結果をまとめております。当書に掲載されている企業情報には、Abbott Labo...

世界の腎臓がん診断市場予測（～2028年）：免疫組織化学、尿分析、血液化学検査、その他

Global Kidney Cancer Diagnostics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E8015 2022年5月 107Pages
腎臓がん診断市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。

乳がんバイオマーカーのグローバル市場インサイト・予測（～2028年）

Global Breast Cancer Biomarkers Market Insights, Forecast to 2028
QY2207C3636 2022年7月11日 109Pages
新型コロナウイルス感染症のパンデミックにより、世界の乳がんバイオマーカーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に乳がんバイオマー...

前立腺特異抗原（PSA）検査のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Prostate Specific Antigen (PSA) Testing Market The global Prostate Specific Antigen (PSA) Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this healt…
肝臓がん診断の世界市場2022年-2030年 Summary: In this Liver Cancer Diagnostics Market report, offers a comprehensive analysis of key market trends in the global Liver Cancer Diagnostics market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which are b…
次世代がん診断の世界市場2022年-2030年 Summary: In this Next Generation Cancer Diagnostics Market report, offers a comprehensive analysis of key market trends in the global Next Generation Cancer Diagnostics market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and ch…
世界の腎臓がん診断市場予測（～2028年）：免疫組織化学、尿分析、血液化学検査、その他 The Kidney Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
乳がんバイオマーカーのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Breast Cancer Biomarkers Market Due to the COVID-19 pandemic, the global Breast Cancer Biomarkers market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022…